Systemic mastocytosis (SM) is characterized by an abnormal accumulation of mast cells, a type of immune cell present throughout the body that contributes to allergic and inflammatory responses ...

Indolent systemic mastocytosis (ISM) is one of the five subtypes of systemic mastocytosis, a condition characterized by the ...

Because of the often nonspecific nature of MCL, diagnostic efforts need to be better streamlined to reduce the risk of misdiagnosis.

Duke University blood cancer specialist Lindsay Rein, MD, has developed a rare expertise in myeloproliferative neoplasms ...

Further testing led to a surprising diagnosis of systemic mastocytosis (SM), a rare blood disorder that causes certain immune cells, called mast cells, to build up in different parts of the body.

Blueprint Medicines' strong pipeline and Ayvakit growth make it promising. Read why BPMC stock is rated "Hold" due to high ...

Healthcare Analysts provide expert insights on current and emerging treatments for Systemic Mastocytosis (relevant companies Blueprint ...

“The expanded SUMMIT data presented at AAAAI 2025 reinforce our belief that bezuclastinib can rapidly and meaningfully improve a wide variety of symptoms that impact the daily lives of patients with ...